Page last updated: 2024-11-13

mycalamide b

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

mycalamide B: structure given in first source; isolated from marine sponges; ChemLine lists mycalamide B incorrectly under RN 122752-21-0 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID46173853
CHEBI ID80858
MeSH IDM0165876

Synonyms (6)

Synonym
mycalamide b
C17009
124512-46-5
CHEBI:80858
DTXSID50673001
(2s)-2-hydroxy-n-{(4s,4as,8s,8ar)-6-[(2s)-3-hydroxy-2-methoxypropyl]-8-methoxy-7,7-dimethylhexahydro-2h-pyrano[3,2-d][1,3]dioxin-4-yl}-2-[(2r,5r,6r)-2-methoxy-5,6-dimethyl-4-methylideneoxan-2-yl]acetamide (non-preferred name)

Research Excerpts

Overview

Mycalamide B (MycB) is a marine sponge-derived natural product with potent antitumor activity.

ExcerptReferenceRelevance
"Mycalamide B (MycB) is a marine sponge-derived natural product with potent antitumor activity. "( Inhibition of eukaryotic translation elongation by the antitumor natural product Mycalamide B.
Bhat, S; Dang, Y; Eyler, DE; Green, R; Jewett, JC; Liu, JO; Rawal, VH; Schneider-Poetsch, T, 2011
)
2.04
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
organic heterobicyclic compound
oxacycleAny organic heterocyclic compound containing at least one ring oxygen atom.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (12.50)18.7374
1990's1 (12.50)18.2507
2000's3 (37.50)29.6817
2010's3 (37.50)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.47

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.47 (24.57)
Research Supply Index2.20 (2.92)
Research Growth Index4.66 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.47)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (12.50%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (87.50%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]